Please join Kenneth Owen, Assistant Professor in Integrated Biomedical Engineering & Health Sciences, and Associate Vice-President, Research (Commercialization & Entrepreneurship) Leyla Soleymani, in hosting keynote speaker John Valliant of Fusion Pharmaceuticals.
John will discuss how he transformed his groundbreaking radiopharmaceutical research into a thriving business – Fusion Pharmaceuticals – which was recently acquired by AstraZeneca for $2B (US).